Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

NCT00914459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Kuopio University Hospital Kuopio, Finland
  • LTD Medinvesti- Institute of hematology and transfusiology Tbilisi, Georgia
  • Centro di Riferimento Regionale per la cura dell'Emofilia e delle Malattie Emorragiche Congenite Parma, Italy
  • Spitalul Clinic Judetean de Urgenta Craiova Craiova, Dolj, Romania
View all 17 locations
View Trial Details
Completed

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

NCT01692925

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Frankfurt/M., Germany
  • Novo Nordisk Investigational Site Riga, Latvia
  • Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
View Trial Details
Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

NCT01205724

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site Lexington, Kentucky, United States
  • Novo Nordisk Investigational Site Baltimore, Maryland, United States
  • Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States
View all 18 locations
View Trial Details
Completed

A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

NCT01238367

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Itabashi-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Kashihara-shi, Nara, Japan
  • Novo Nordisk Investigational Site Maebashi-shi, Gunma, Japan
  • Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan
View Trial Details
Completed

Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A

NCT02093897

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study Site Aurora, Colorado, United States
  • Study Site Chicago, Illinois, United States
  • Study Site Melbourne, Victoria, Australia
  • Study Site Linz, Austria
View all 37 locations
View Trial Details
Completed

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

NCT00956345

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Cincinnati, Ohio, United States
  • Novo Nordisk Investigational Site Portland, Oregon, United States
  • Novo Nordisk Investigational Site Richmond, Virginia, United States
  • Novo Nordisk Investigational Site Copenhagen, Denmark
View all 19 locations
View Trial Details

Related conditions